Lexaria Bioscience Corp. SEC filings LEXX
Lexaria Bioscience Corp. has 1,000 filings in SEC EDGAR's recent list, going back to Aug 25, 2009. Its latest annual report, Form 10-K, was filed on Nov 28, 2025 for the period ended Aug 31, 2025. The latest quarterly report (Form 10-Q) was filed on Jul 13, 2026, covering the quarter ended May 31, 2026. The most recent current report (Form 8-K) was filed on Sep 9, 2026 (material agreement, unregistered share sale, regulation fd disclosure). The company's fiscal year ends on August 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14A | Proxy statement | Dec 10, 2025 | Jan 27, 2026 |
| DEF 14A | Proxy statement | Nov 27, 2024 | Jan 14, 2025 |
| PRE 14A | Preliminary proxy statement | Nov 12, 2024 | Nov 7, 2024 |
| DEF 14A | Proxy statement | Mar 6, 2024 | Feb 27, 2024 |
| DEF 14A | Proxy statement | Aug 23, 2023 | Aug 8, 2023 |
| PRE 14A | Preliminary proxy statement | Aug 9, 2023 | Aug 8, 2023 |
| DEF 14A | Proxy statement | Mar 22, 2023 | Mar 17, 2023 |
| PRE 14A | Preliminary proxy statement | Mar 10, 2023 | Mar 3, 2023 |
| DEFA14A | Additional proxy material | Apr 13, 2022 | — |
| DEFA14A | Additional proxy material | Apr 13, 2022 | — |
| DEF 14A | Proxy statement | Apr 13, 2022 | Apr 4, 2022 |
| DEF 14A | Proxy statement | May 14, 2021 | May 3, 2021 |
| DEF 14A | Proxy statement | May 26, 2020 | May 13, 2020 |
| PRE 14A | Preliminary proxy statement | May 13, 2020 | May 13, 2020 |
| DEF 14A | Proxy statement | May 22, 2019 | May 15, 2019 |
| DEF 14A | Proxy statement | Feb 25, 2016 | Mar 23, 2016 |
| PRE 14A | Preliminary proxy statement | Feb 5, 2016 | Mar 23, 2016 |
| DEF 14A | Proxy statement | May 20, 2014 | Jun 11, 2014 |
| PRE 14A | Preliminary proxy statement | Apr 10, 2014 | Jun 11, 2014 |
| DEF 14A | Proxy statement | Mar 22, 2013 | Apr 17, 2013 |
| DEF 14A | Proxy statement | Mar 28, 2012 | Apr 30, 2012 |
| DEF 14A | Proxy statement | May 13, 2011 | Jun 17, 2011 |
| DEF 14A | Proxy statement | Feb 2, 2010 | Feb 2, 2010 |
| PRE 14A | Preliminary proxy statement | Jan 20, 2010 | Jan 20, 2010 |
Showing 24 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- LEXX (Nasdaq)
- Fiscal year ends
- August 31
- Incorporated in
- NV
- Headquarters
- Kelowna, British Columbia, Canada
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1348362
- Former names
- Lexaria Corp. (until May 11, 2016); LEXARIA CORP. (until May 11, 2016)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.